Industry: Life Sciences, Medical Technology
Investors: Fresenius Medical Care & RMG
Business Overview MedaSorb Technologies (OTC BB: MSBT) has developed a new platform technology that efficiently removes toxic compounds from the bloodstream. Current state-of-the-art blood purification techniques are not designed for this purpose and are inefficient at removing these toxins. The Company’s products, which incorporate a proprietary adsorbent polymer technology, are known medically as hemoperfusion devices and have many potential healthcare applications.